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Background  :  The  role  of  Helicobacter  pylori  (H.  pylori)  in  the  pathogenesis  of  coronary  artery  disease  (CAD)  is  still 
controversial,  and  the  relation  between  current  H.  pylori  infection  and  CAD  has  not  been  fully  examined.  This  study 
evaluated  the  relation  between  H.  pylori  infection  as  confirmed  by  gastroduodenoscopic  biopsy  and  CAD.
Methods  :  We  determined  the  presence  of  H.  pylori  infections,  via  gastroduodenoscopy,  in  88  patients  of  the  normal 
coronary  angiographic  group  and  also  in  175  patients  of  the  CAD  group,  and  the  latter  patients  had  more  than  50% 
coronary  stenosis  angiographically  demonstrated.  We  excluded  those  patients  with  a  history  of  previous  H.  pylori 
eradication  and/or  malignancy.  A  small  piece  of  tissue  from  the  antrum,  which  was  obtained  by  gastroduodenoscopic 
biopsy,  was  stained  by  Warthin-starry  silver  stain.  We  defined  a  negative  staining  result  that  there  was  no  stained 
tissue  in  the  sample  and  the  stained  tissue  was  also  positive  for  H.  pylori  infection. 
Results  :  There  was  no  significant  difference,  except  for  gender,  age,  smoking  and  high  density  lipoprotein 
cholesterol  (HDL-c),  of  the  demographic  and  laboratory  characteristics  between  the  groups.  Twenty  seven  (30.7%) 
patients  of  the  normal  control  group  and  71  (40.6%)  patients  of  the  CAD  group  were  positive  of  H.  pylori  infection,  yet 
there  was  no  statistical  difference.  We  angiographically  followed  up  the  80  patients  of  the  CAD  group  who  were  treated 
by  percutaneous  coronary  intervention  (PCI)  at  6  to  9  months  after  their  primary  intervention.  Twenty  two  (37.9%)  of 
the  58  patients  of  the  H.  pylori  negative  group  and  10  (45.5%)  of  the  22  patients  of  the  H.  pylori  positive  group  were 
treated  with  reintervention,  but  reintervention  was  also  not  significantly  different  between  the  group  with  H.  pylori 
infection  and  the  group  without  the  infection.
Conclusions  :  These  data  indicated  that  H.  pylori  infection  had  a  modest  influence  on  CAD  and  progressive 
atheroma,  but  the  showed  a  tendency  to  increase.  Further  studies  are  needed  to  evaluate  the  relationship  between 
H.  pylori  infection  and  CAD.
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INTRODUCTION
Helicobacter  pylori  (H.  pylori)  infection  is  an  etiological  factor 
for  the  development  of  peptic  ulcer  and  gastric  cancer
1).  Several 
preliminary  reports  have  suggested  that  chronic  infections  by  H. 
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with  atherosclerosis  and  vascular  disease
2, 3).  However,  most 
prospective  studies  have  not  confirmed  the  association  between 
chronic  infections  and  coronary  artery  disease  (CAD)
4-6)  and  all 
the  recent  prospective  studies  and  meta-analyses  on  the 
association  between  Chlamydia  pneumoniae  (C.  pneumoniae) 
and/or  Cytomegalovirus  infection  and  coronary  disease  have 
produced  negative  results.  This  suggests  there  is  only  a 
possible  mild  association,  and  the  previous  studies  virtually 
excluded  a  major  role  for  H.  pylori  infection  as  a  risk  factor
7, 8). 
Several  studies  have  assessed  the  association  between  the 
cytotoxin-associated  gene-A  (CagA)  status  and  vascular 
diseases  (either  coronary  disease  or  cerebrovascular  disease), 
and  these  studies  have  produced  mixed  results
9-13).  The  rate  of 
positivity  for  H.  pylori  infection  among  Korean  adults  is  reported 
to  reach  as  much  as  70%
14-16).  Though  the  prevalence  of 
coronary  artery  disease  among  Asians  has  been  reported  to  not 
be  much  different  from  that  of  Caucasians,  in  spite  of  the  high 
rate  of  H.  pylori  infection  for  both  races
17),  the  exact  relation 
between  H.  pylori  and  cardiovascular  risk  factors  might  be  an 
important  issue  to  reduce  the  incidence  of  cardiovascular 
disease
18). 
The  objectives  of  the  present  study  were  to  reveal  and 
examine  the  relation  between  the  H.  pylori  infection  of  the 
stomach  and  CAD,  and  to  angiographically  determine,  after  6  to 
9  months,  the  influence  of  H.  pylori  infection  on  the 
reintervention  of  patients  who  were  treated  by  percutaneous 
coronary  intervention  (PCI).
MATERIALS AND METHODS
The  subjects  of  this  study  were  those  patients  who  were 
admitted  to  the  Cardiac  Catheterization  Laboratory  at  Daejeon 
St.  Mary's  Hospital  and  Kangnam  St.  Mary's  Hospital  for 
coronary  angiography,  and  these  patients  were  suspected  to 
have  developed  CAD;  we  prospectively  enrolled  those  patients 
who  were  seen  from  January  2003  to  June  2006.  All  the 
patients  underwent  physical  examinations.  In  terms  of  smoking 
behavior,  the  patients  were  divided  into  two  groups:  smokers 
and  non-smokers.  Patients  who  had  stopped  smoking  for  10 
years  or  less  were  classified  as  smokers.  The  definition  of 
hypertension  was  the  current  use  of  antihypertensive  drugs,  or 
it  was  based  on  the  seventh  report  of  the  Joint  National 
Committee  on  the  Detection,  Evaluation  and  Treatment  of  High 
Blood  Pressure.  Hyperlipidemia  was  defined  as  the  state  where 
the  serum  cholesterol  level  was  200  mg/dL  and  greater,  or  the 
current  use  of  a  hypolipidemic  drug.  The  definition  of  diabetes 
was  based  on  the  criteria  of  the  American  Diabetes  Association, 
or  the  current  use  of  oral  hypoglycemic  agents  or  insulin.  The 
decision  to  perform  coronary  angiography  was  based  on  those 
symptoms  that  were  consistent  with  this  diagnosis  and  also  an 
abnormal  electrocardiogram  (either  baseline  or  stress).  Both  the 
right  and  left  coronary  arteries  were  studied  in  at  least  two 
oblique  projections  (RAO  30°and  LAO  60°).  The  CAD  group 
that  was  included  in  the  study  consisted  of  those  patients  who 
had  at  least  one  coronary  artery  lesion  that  occupied  at  least 
50%  of  the  luminal  diameter,  as  noted  on  the  coronary  angio-
graphy.  The  patients  who  had  normal  coronary  angiographic 
results  were  selected  as  the  normal  control  group. 
Gastroduodenoscopy  was  done  in  both  groups  within  1  month 
before  or  after  performance  of  the  coronary  angiogram.  Some 
patients  were  excluded  if  they  had  a  platelet  count  of  less  than 
100,000/mm
3,  acute  myocardial  infarction  within  the  48  hours, 
primary  PCI,  a  history  of  previous  treated  PCI  or  coronary  artery 
bypass  graft  or  H.  pylori  eradication  or  malignancy.  A  small  tiny 
tissue  of  the  antrum  that  was  taken  by  gastroduodenoscopic 
biopsy  was  stained  via  Warthin-starry  silver  stain.  A  negative 
staining  result  was  defined  as  there  was  no  stained  tissue  in  the 
sample  and  the  stained  tissue  was  positive  for  H.  pylori 
infection.  More  than  70%  of  the  coronary  stenotic  patients  in  the 
CAD  group  were  angiographically  treated  with  PCI.  Procedural 
success  was  defined  as  the  final  diameter  of  the  stenosis  was 
35%  or  less  and  there  was  no  flow-limiting  dissection. 
Intracoronary  stents  were  recommended  only  for  those  patients 
with  suboptimal  angiographic  results.  We  angiographically 
followed  up,  at  between  6  to  9  months,  the  patients  of  the  CAD 
group  who  were  treated  by  PCI  and  we  then  we  evaluated  their 
reintervention;  their  new  stonotic  lesions  were  due  to  new 
coronary  stenotic  lesion  and  in-stent  restenosis.  New  coronary 
stenotic  lesion  was  defined  when  the  newly  developed  lumen 
occupied  more  than  50%  of  the  vessel  lumen,  and  in-stent 
restenosis  was  defined  when  the  blockage  was  more  than  50% 
of  the  stent  lumen.  The  height  and  weight  of  each  patient  was 
measured  and  the  body  mass  index  (BMI)  was  calculated  as 
kg/m.  After  more  than  12  hours  of  fasting,  a  blood  sample  was 
taken  before  the  coronary  angiogram.  The  blood  glucose  level, 
total  cholesterol,  triglyceride  (TG),  high-density  lipoprotein 
cholesterol  (HDL-c)  and  low-density  lipoprotein  cholesterol 
(LDL-c)  and  so  on  were  measured  by  an  enzymatic  method 
and  using  an  automatic  analyzer  (Hitachi  747).  Highly  sensitive 
C-reactive  protein  (hsCRP)  was  measured  by  immunon-
ephelometry  (Nephelometry,  Behring  Nephelometer  II,  Dade 
Behring  Marburg,  Germany).
Statistical  analysis
Statistical  analyses  were  performed  with  using  SPSS11 
statistical  analysis  software.  Unless  otherwise  noted,  any  test  of 
a  hypothesis  was  two-sided  and  the  level  of  significance  was 
set  at  5%.  Potential  associations  between  the  clinical  and 
biologic  parameters  were  tested  for  by  univariate  analysis  with The  Korean  Journal  of  Internal  Medicine  :  Vol.  22,  No.  3,  September  2007 154
 
Normal  Control 
(N=88)
CAD 
(N=175)
p
Male  n  (%)
Age  (years)  mean±SD
Diabetes  n  (%)
Hypertension  n  (%)
Smoker  n  (%)
Hyperlipidemia  n  (%)
BMI  (kg/m²)  mean±SD
FBS  (mg/dL)  mean±SD
Cr  (mg/dL)  mean±SD
Uric  acid  (mg/dL)  mean±SD
T-chol  (mg/dL)  mean±SD
TG  (mg/dL)  mean±SD
HDL-c  (mg/dL)  mean±SD
LDL-c  (mg/dL)  mean±SD
hsCRP  (mg/dL)  mean±SD
33  (37.5)
59.0±10.7
20  (23.2)
44  (50.0)
28  (32.1)
11  (12.5)
24.1±3.5
108.1±24.6
1.09±0.95
5.4±1.7
175.7±34.0
135.7±70.9
54.7±46.1
94.5±56.1
1.53±7.0
111  (63.4)
62.6±8.6
51  (29)
89  (51)
90  (51.6)
20  (11.4)
24.0±3.1
118.7±49.3
1.39±1.70
5.7±2.0
173.7±43.4
144.7±84.1
45.1±13.6
100.8±35.4
0.81±1.6
0.001
0.007
NS
NS
0.013
NS
NS
NS
NS
NS
NS
NS
0.046
NS
NS
p,  p-value;  NS,  non-significant;  CAD,  coronary  artery  disease;  BMI,  body  mass  index;  FBS,  fasting  blood  sugar;  Cr,  creatinine; 
T-chol,  total  cholesterol;  TG,  triglyceride;  HDL-c,  high  density  lipoprotein  cholesterol;  LDL-c,  low  density  lipoprotein  cholesterol; 
hsCRP,  Highly  sensitive  C-reactive  protein;  SD,  standard  deviation
Table  1.  Comparison  of  the  demographics  and  coronary  risk  factors  of  the  normal  control  group  and  the  coronary  artery  disease  group
 
H.  pylori  negative
(N=58)
H.  pylori  positive
(N=22)
p
Reintervention  n  (%) 22  (37.9%) 10  (45.5%) NS
p,  p-value;  NS,  non-significant;  H.  pylori,  helicobacter  pylori
Table  2.  Reintervention  after  percutaneous  coronary  intervention  according  to  the  status  of  Helicobacter  pylori  infection
Figure 1.  There  was  no significant  difference between  the  normal 
control  group  and  the  CAD  group.  NS,  non-significant;  H.  pylori, 
Helicobacter  pylori;  CAD,  coronary  artery  disease.
using  the  Student  t  or  the  chi-square  test.  The  results  were 
expressed  as  means±SDs.
RESULTS
The  series  originally  consisted  of  88  cases  for  the  angio-
graphically  documented  normal  control  group  and  175 
angiographically  documented  cases  for  the  CAD  group. 
Compared  with  the  normal  control  group,  the  patients  with  CAD 
were  significantly  older  and  smoked  more  and  among  them,  the 
male  patients  outnumbered  their  female  counterparts;  in 
addition,  the  male  CAD  patients  had  lower  serum  concentrations 
of  HDL-c  (Table  1).  Twenty  seven  (30.7%)  patients  of  the 
normal  control  group  and  71  (40.6%)  patients  of  the  CAD  group 
were  positive  for  H.  pylori  infection.  The  incidence  of  H.  pylori 
infection  for  the  CAD  group  showed  a  tendency  to  increase,  but 
there  was  no  statistical  difference  between  the  groups  (Figure  1).
We  angiographically  followed  up  the  80  patients  of  the  CAD 
group  who  were  treated  by  PCI  after  6  to  9  months  (the 
re-intervention  group).  Twenty  two  (37.9%)  of  the  58  H.  pylori 
negative  patients  and  10  (45.5%)  of  the  22  H.  pylori  positive 
patients  were  treated  with  reintervention,  and  the  rate  of 
reintervention  was  also  not  significantly  different  between  the 
two  groups  (Table  2).  The  reintervention  was  caused  by  new 
coronary  stenotic  lesion  and  in-stent  restenosis.  New  coronary 
stenotic  lesions  were  noted  in  18  (31.0%)  of  the  58  H.  pylori 
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patients,  and  the  number  of  patients  with  in-stent  restenosis 
were  8  (13.8%)  and  2  (9.1%),  respectively.  The  previous  stents 
of  the  in-stent  restenosis  patients  were  all  bare-metal  stents. 
There  was  no  significant  difference  between  the  group  with  H. 
pylori  infection  and  the  group  without  the  infection.
DISCUSSION
Seroepidemiologic  studies  have  demonstrated  that  athero-
sclerosis  is  associated  with  several  infectious  pathogens, 
including  H.  pylori
2, 19),  C.  pneumoniae
20, 21)  and  cytomegalovirus
22). 
Both  H.  pylori  infection  and  CAD  are  associated  with  the 
socioeconomic  status  of  patients,  and  both  H.  pylori  infection 
and  CAD  increase  with  age
23, 24).  Finding  a  causal  association 
between  the  two  diseases  would  be  very  important  in  that  H. 
pylori  can  be  screened  for  and  it  is  amenable  to  treatment. 
There  is  also  the  possibility  of  a  future  vaccine  that  might  be 
given  in  childhood  and  also  performing  eradication  of  H.  pylori  in 
adulthood.  Previous  studies  that  examined  the  relation  of  both 
diseases  have  used  a  variety  of  criteria  to  define  the  presence 
or  absence  of  CAD.  In  addition,  all  of  the  control  subjects  in  the 
other  previous  studies  have  lacked  angiographic  confirmation
2,
25-27).  Therefore,  to  minimize  any  misclassification  of  our 
patients,  we  used  angiographic  confirmation  to  determine  the 
presence  or  absence  of  CAD  in  both  the  cases  and  the 
controls.  In  the  other  studies,  the  presence  or  absence  of  H. 
pylori  seropositivity  was  used  to  diagnose  H.  pylori  infection,  yet 
in  our  study,  this  was  diagnosed  by  gastroduodenoscopic 
biopsy
1, 2, 4, 6, 7).
  The  results  of  our  studies  revealed  little  association  between 
H.  pylori  infection  and  CAD,  but  the  rate  of  H.  pylori  infection  for 
the  CAD  group  showed  a  tendency  to  increase.  According  to  a 
recent  study,  chronic  infection  with  H.  pylori  may  be  involved  in 
the  development  of  atherosclerosis  via  endothelial  dysfunction 
and  systemic  and  vascular  inflammation
28),  and  definite  evidence 
of  an  association  between  CagA-positive  H.  pylori  and  ischemic 
heart  disease  will  probably  come  about  only  from  prospective 
studies.  We  found  three  group  case-control  studies
4, 12, 13)  that 
had  remarkably  similar  results;  these  studies  showed  the  weak 
association  between  CagA-positive  H.  pylori  and  the  occurrence 
of  fatal  and  nonfatal  myocardial  infarction  during  the  follow-up 
period,  with  a  pooled  odds  ration  (OR)  of  1.26  (95%  confidence 
interval:  1.05-1.51),  which  corresponds  to  a  relative  risk  of  1.13. 
These  findings  virtually  rule  out  any  major  relationship  between 
the  CagA  status  and  ischemic  heart  disease.  A  possible  limit  of 
these  studies  is  that  they  were  performed  in  the  same  country 
with  a  population  that  had  a  relatively  high  prevalence  of  CagA 
strains.  However,  the  reported  13%  increase  in  the  risk  of 
cardiac  events  may  still  have  significant  epidemiological 
consequences,  as  infection  by  CagA-positive  H.  pylori  is  present 
in  approximately  30%  of  the  population.  In  addition,  H.  pylori 
may  be  an  independent  risk  factor  for  restenosis,  and  other 
studies  have  reported  that  H.  pylori  eradication  significantly 
attenuates  the  reduction  in  the  coronary  artery  lumen  in  CAD 
patients  after  PCI
29, 30).  In  our  study,  the  relation  between  H. 
pylori  and  reintervention  after  PCI  also  had  a  tendency  to 
increase,  but  there  was  no  significant  difference. 
There  are  several  limitations  in  our  study.  The  study  included 
a  small  number  of  patients  and  we  lacked  information  about  the 
virulence  of  H.  pylori.  The  number  and  rate  of  the  followed-up 
patients  that  underwent  reintervention  were  also  small.  We 
believe  that  future  studies  that  will  focus  on  the  virulent  H.  pylori 
strains  in  a  large  group  of  patients  are  needed  to  determine  the 
probable  role  of  H.  pylori  for  CAD  and  restenosis.
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